Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.32 EUR | -3.40% | +0.52% | -23.94% |
May. 08 | Terhi Kauppi Resigns as Chief Financial Officer of Remedy Entertainment Plc, Effective June 30, 2024 | CI |
Apr. 29 | Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.94% | 294M | - | ||
+13.11% | 3,161B | C+ | ||
+11.55% | 87.62B | B | ||
+7.38% | 79.59B | B+ | ||
-13.48% | 54.14B | B+ | ||
+25.92% | 48.15B | D+ | ||
-24.39% | 46.81B | B- | ||
+35.49% | 47.69B | D+ | ||
+80.54% | 42B | D+ | ||
-6.24% | 25.77B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- REMEDY Stock
- Ratings Remedy Entertainment Oyj